NFKB1 and neoplasm: The schematic diagram of the present study (Figure 9) shows that chemoresistance-associated silencing of miR-4454 promotes CRC aggression, reverted through the overexpression of miR-4454 by targeting GNL3L (tumor initiation or maintenance-related gene) and the NFκB pathway.